Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases
Authors:
Open Access
- 1 August 2024
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (8) , e2428280
Abstract
The popularity of branded semaglutide is surging, with widespread media coverage, viral social media exposure, and celebrity endorsements.1 Although Wegovy (Novo Nordisk) is approved for long-term weight management, Ozempic (Novo Nordisk) (only approved for type 2 diabetes) is often used off-label for this purpose. Global regulatory agencies, including the US Food and Drug Administration (FDA), European Medicines Agency, and World Health Organization (WHO), have warned about fake versions driven by patient demand, high cost, and shortages. Illegal online pharmacies, which operate without valid licenses and sell medicines like semaglutide without prescription, represent a consumer risk for ineffective and dangerous products.Keywords
This publication has 3 references indexed in Scilit:
- As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight LossJAMA, 2023
- Multifactor Quality and Safety Analysis of Antimicrobial Drugs Sold by Online Pharmacies That Do Not Require a Prescription: Multiphase Observational, Content Analysis, and Product Evaluation StudyJMIR Public Health and Surveillance, 2022
- A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicinesJournal of Pharmaceutical Policy and Practice, 2020